Today: 11 June 2026
Browse Category

NYSE:IHS 13 January 2026 - 19 February 2026

Macquarie share price rises with ASX at record highs — here’s what investors watch next

Macquarie share price rises with ASX at record highs — here’s what investors watch next

Macquarie Group shares closed up 1.6% at A$223.00 as the S&P/ASX 200 hit a record before ending 0.9% higher. Australia’s unemployment rate held at 4.1% in January, with jobs rising by 17,800. The Reserve Bank raised its cash rate to 3.85% this month and signaled uncertainty on future moves. Investors await January inflation data on Feb. 25 and Macquarie’s full-year results on May 8.
19 February 2026
··
Macquarie share price ends higher after $685 million IHS tower deal — what MQG investors watch next

Macquarie share price ends higher after $685 million IHS tower deal — what MQG investors watch next

Macquarie shares closed up 0.6% at A$219.60 after its asset management arm agreed to buy IHS Towers’ South American tower portfolio for $685 million. The deal is expected to close later in 2026. IHS Towers is exiting Latin America and said the portfolio includes about 8,860 sites. Macquarie’s next major event is its full-year results on May 8.
18 February 2026
··

Stock Market Today

  • Coupang Shares Rise After South Korea Imposes $410 Million Data Breach Fine
    June 11, 2026, 10:43 AM EDT. Coupang, the New York-listed South Korean e-commerce company, saw its shares rise 5.6% to $15.96 following a record $410 million fine from the Personal Information Protection Commission (PIPC) for a major data breach affecting over 37 million users. The fine includes penalties for a November 2025 incident and unauthorized data tracking via a third-party ad program. Coupang expects the penalty to impact its second-quarter operating expenses but plans to seek judicial relief. The regulator attributed the breach to a lack of proper safety measures, estimating the fine at approximately 1.4% of Coupang's 2025 revenue of 45 trillion won. Investors are monitoring whether this will lead to lasting effects on customer trust and profit margins.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Go toTop